1.
Mele A, Sparaventi G, Guiducci B, Nicolini G, d’Adamo F, Leopardi G, Delfini C, Piccaluga P, Visani G. Gemtuzumab ozogamicin plus cytarabine determines complete remission in acute myeloid leukemia refractory to a double conventional treatment: a case report. Haematologica [Internet]. 2004Jun.1 [cited 2026Nov.17];89(6_Suppl):ECR18-ECR18. Available from: https://haematologica.org/article/view/3135